BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 27887582)

  • 1. YPTB3816 of Yersinia pseudotuberculosis strain IP32953 is a virulence-related metallo-oligopeptidase.
    Atas A; Seddon AM; Ford DC; Cooper IA; Wren BW; Oyston PC; Karlyshev AV
    BMC Microbiol; 2016 Nov; 16(1):282. PubMed ID: 27887582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the phoPQ operon in the pathogenesis of the fully virulent CO92 strain of Yersinia pestis and the IP32953 strain of Yersinia pseudotuberculosis.
    Bozue J; Mou S; Moody KL; Cote CK; Trevino S; Fritz D; Worsham P
    Microb Pathog; 2011 Jun; 50(6):314-21. PubMed ID: 21320584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A putative DNA adenine methyltransferase is involved in Yersinia pseudotuberculosis pathogenicity.
    Pouillot F; Fayolle C; Carniel E
    Microbiology (Reading); 2007 Aug; 153(Pt 8):2426-2434. PubMed ID: 17660407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence.
    Grabenstein JP; Marceau M; Pujol C; Simonet M; Bliska JB
    Infect Immun; 2004 Sep; 72(9):4973-84. PubMed ID: 15321989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome Scale Analysis Reveals IscR Directly and Indirectly Regulates Virulence Factor Genes in Pathogenic
    Balderas D; Mettert E; Lam HN; Banerjee R; Gverzdys T; Alvarez P; Saarunya G; Tanner N; Zoubedi A; Wei Y; Kiley PJ; Auerbuch V
    mBio; 2021 Jun; 12(3):e0063321. PubMed ID: 34060331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pyruvate-tricarboxylic acid cycle node: a focal point of virulence control in the enteric pathogen Yersinia pseudotuberculosis.
    Bücker R; Heroven AK; Becker J; Dersch P; Wittmann C
    J Biol Chem; 2014 Oct; 289(43):30114-32. PubMed ID: 25164818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Global discovery of small RNAs in Yersinia pseudotuberculosis identifies Yersinia-specific small, noncoding RNAs required for virulence.
    Koo JT; Alleyne TM; Schiano CA; Jafari N; Lathem WW
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):E709-17. PubMed ID: 21876162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IscR is essential for yersinia pseudotuberculosis type III secretion and virulence.
    Miller HK; Kwuan L; Schwiesow L; Bernick DL; Mettert E; Ramirez HA; Ragle JM; Chan PP; Kiley PJ; Lowe TM; Auerbuch V
    PLoS Pathog; 2014 Jun; 10(6):e1004194. PubMed ID: 24945271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure and function of cytidine monophosphate kinase from Yersinia pseudotuberculosis, essential for virulence but not for survival.
    Walker NJ; Clark EA; Ford DC; Bullifent HL; McAlister EV; Duffield ML; Acharya KR; Oyston PC
    Open Biol; 2012 Dec; 2(12):120142. PubMed ID: 23271832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative study of the role of the yadA, invA, and psaA genes in the pathogenicity of Yersinia pseudotuberculosis].
    Karataev GI; Markov AR; Siniashina LN; Miller GG; Klitsunova NV; Titova IV; Semin EG; Goncharova NI; Pokrovskaia MS; Amelina IP; Amoako K; Smirnov GB
    Mol Gen Mikrobiol Virusol; 2008; (4):10-8. PubMed ID: 19172873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complete genome sequence of Yersinia pseudotuberculosis IP31758, the causative agent of Far East scarlet-like fever.
    Eppinger M; Rosovitz MJ; Fricke WF; Rasko DA; Kokorina G; Fayolle C; Lindler LE; Carniel E; Ravel J
    PLoS Genet; 2007 Aug; 3(8):e142. PubMed ID: 17784789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galleria mellonella as an alternative infection model for Yersinia pseudotuberculosis.
    Champion OL; Cooper IAM; James SL; Ford D; Karlyshev A; Wren BW; Duffield M; Oyston PCF; Titball RW
    Microbiology (Reading); 2009 May; 155(Pt 5):1516-1522. PubMed ID: 19383703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunization with a DNA adenine methylase over-producing Yersinia pseudotuberculosis vaccine confers robust cross-protection against heterologous pathogenic serotypes.
    Kubicek-Sutherland JZ; Heithoff DM; Ersoy SC; Shimp WR; Mahan MJ
    Vaccine; 2014 Mar; 32(13):1451-9. PubMed ID: 24508035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of YopE and YopT activities in counteracting host signalling responses to Yersinia pseudotuberculosis infection.
    Viboud GI; Mejía E; Bliska JB
    Cell Microbiol; 2006 Sep; 8(9):1504-15. PubMed ID: 16922868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased plasmid copy number is essential for Yersinia T3SS function and virulence.
    Wang H; Avican K; Fahlgren A; Erttmann SF; Nuss AM; Dersch P; Fallman M; Edgren T; Wolf-Watz H
    Science; 2016 Jul; 353(6298):492-5. PubMed ID: 27365311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population structure and evolution of pathogenicity of Yersinia pseudotuberculosis.
    Ch'ng SL; Octavia S; Xia Q; Duong A; Tanaka MM; Fukushima H; Lan R
    Appl Environ Microbiol; 2011 Feb; 77(3):768-75. PubMed ID: 21131531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 induction is an important virulence function of the Yersinia pseudotuberculosis type III effector YopM.
    McPhee JB; Mena P; Zhang Y; Bliska JB
    Infect Immun; 2012 Jul; 80(7):2519-27. PubMed ID: 22547545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virulence characteristics of Yersinia pseudotuberculosis isolated from breeding monkeys in Japan.
    Iwata T; Une Y; Okatani AT; Kato Y; Nakadai A; Lee K; Watanabe M; Taniguchi T; Elhelaly AE; Hirota Y; Hayashidani H
    Vet Microbiol; 2008 Jun; 129(3-4):404-9. PubMed ID: 18242014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of a novel Toll/interleukin-1 receptor (TIR)-domain containing virulence protein of Y. pseudotuberculosis among Far East scarlet-like fever serotype I strains.
    Nörenberg D; Wieser A; Magistro G; Hoffmann C; Meyer C; Messerer M; Schubert S
    Int J Med Microbiol; 2013 Dec; 303(8):583-94. PubMed ID: 24018301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth of Yersinia pseudotuberculosis in human plasma: impacts on virulence and metabolic gene expression.
    Rosso ML; Chauvaux S; Dessein R; Laurans C; Frangeul L; Lacroix C; Schiavo A; Dillies MA; Foulon J; Coppée JY; Médigue C; Carniel E; Simonet M; Marceau M
    BMC Microbiol; 2008 Dec; 8():211. PubMed ID: 19055764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.